Access Infinity published a whitepaper exploring the challenge of GLP-1s moving beyond obesity, value stories, pricing architecture, and indication sequencing.

Access Infinity exists to help pharma companies confront their challenges head-on. We began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies. We’ve since introduced our market-redefining digital tools, Access Hub, Evidence Library and NURO to help market access teams work smarter, faster and more efficiently with valuable insights at their fingertips. Access Hub helps users track Global market access KPIs and launch activities. It provides Senior Management a single source of truth for tracking reimbursement metrics across multiple products, indications, and regions. NURO is a comprehensive data platform that combines HTA insights, clinical evidence, pricing intelligence, among other critical business insights under a single roof. With +450 data points for every single approved product across all major markets, competitive benchmarking has never been easier. Simply apply relevant matching criteria to identify product analogues in seconds. Evidence Library is a cloud-based platform that facilitates medical/HEOR teams to store, analyse, identify & easily manage evidence generation projects and publications of interest. This tailor-made productivity platform enables effective collaboration from a single repository. Our consultants combine reliable, high-quality data with decades of experience to bring you insights. We are trusted partners to many leading Pharma & Biotech companies on a global scale with projects completed in +40 countries. Your journey to faster, more efficient market access decision-making starts with us. Get in touch to book a meeting with a member of our specialist team, who will be happy to discuss your goals and how we can help.

Founded 2014